Targeting the ghrelin signaling pathway is thought to decipher the mechanisms underlying the association between obesity and hypertension (4) and carry therapeutic significance in the management of energy homeostasis and cardiovascular function (5). Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.